Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by LIHUA DAI
Identification of a Proliferator-Activated Receptor-Γ Antagonist for the Treatment of Type 2 Diabetes Mellitus
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Related publications
In Silico Identification of Novel Glucagon Receptor Antagonist for the Treatment of Type 2 Diabetes Mellitus
Enzyme Engineering
A Synthetic Antagonist for the Peroxisome Proliferator-Activated Receptor Γ Inhibits Adipocyte Differentiation
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Peroxisome Proliferator-Activated Receptor Γ-Mediated Differentiation
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Peroxisome Proliferator-Activated Receptor-Γ (PPARG; PPARγ)
Science-Business eXchange
Mutation Analysis of Peroxisome Proliferator-Activated Receptor-Γ Coactivator-1 (PGC-1) and Relationships of Identified Amino Acid Polymorphisms to Type II Diabetes Mellitus
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Peroxisome Proliferator-Activated Receptor Gene Variation Influences Age of Onset and Progression of Type 2 Diabetes
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Peroxisome Proliferator-Activated Receptor Γ 2 Modulates Late-Pregnancy Homeostatic Metabolic Adaptations
Molecular Medicine
Molecular Medicine
Genetics
Molecular Biology
Insulinization: A Promising Strategy for the Treatment of Type 2 Diabetes Mellitus
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Combination of Peroxisome Proliferator-Activated Receptor Α/Γ Agonists May Benefit Type 2 Diabetes Patients With Coronary Artery Disease Through Inhibition of Inflammatory Cytokine Secretion
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology